Brian Frederick

577 total citations
10 papers, 474 citations indexed

About

Brian Frederick is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Brian Frederick has authored 10 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Genetics. Recurrent topics in Brian Frederick's work include Hemoglobinopathies and Related Disorders (2 papers), Protein Tyrosine Phosphatases (2 papers) and Iron Metabolism and Disorders (2 papers). Brian Frederick is often cited by papers focused on Hemoglobinopathies and Related Disorders (2 papers), Protein Tyrosine Phosphatases (2 papers) and Iron Metabolism and Disorders (2 papers). Brian Frederick collaborates with scholars based in United States and United Kingdom. Brian Frederick's co-authors include Peter D. Adams, D. Schultz, Nilesh Chitnis, Hui Zheng, Constantinos Koumenis, Nancy L. Maas, Dhruv K. Pant, Ekaterina Bobrovnikova-Marjon, Serge Y. Fuchs and Dariusz Pytel and has published in prestigious journals such as Nature Communications, Blood and Molecular Cell.

In The Last Decade

Brian Frederick

10 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Frederick United States 8 321 121 91 65 62 10 474
Beibei Mao China 13 349 1.1× 203 1.7× 61 0.7× 100 1.5× 68 1.1× 26 560
McKenna Feltes United States 5 234 0.7× 126 1.0× 109 1.2× 51 0.8× 41 0.7× 6 473
Nathan Mbong Canada 8 247 0.8× 116 1.0× 68 0.7× 45 0.7× 102 1.6× 10 467
Le Meng United States 10 473 1.5× 211 1.7× 30 0.3× 55 0.8× 43 0.7× 12 542
Jaime Anguiano United States 9 247 0.8× 99 0.8× 191 2.1× 136 2.1× 23 0.4× 11 466
Tatiana Erazo Spain 11 287 0.9× 82 0.7× 51 0.6× 34 0.5× 35 0.6× 15 374
Meredith A. Miller United States 2 289 0.9× 85 0.7× 53 0.6× 42 0.6× 30 0.5× 2 382
Nancy E. Go Canada 15 591 1.8× 74 0.6× 213 2.3× 59 0.9× 39 0.6× 20 737
Ilana Braunstein Israel 13 422 1.3× 188 1.6× 57 0.6× 21 0.3× 26 0.4× 18 525
Nikolai D. Aksenov Russia 10 244 0.8× 39 0.3× 30 0.3× 56 0.9× 46 0.7× 14 338

Countries citing papers authored by Brian Frederick

Since Specialization
Citations

This map shows the geographic impact of Brian Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Frederick more than expected).

Fields of papers citing papers by Brian Frederick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Frederick. The network helps show where Brian Frederick may publish in the future.

Co-authorship network of co-authors of Brian Frederick

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Frederick. A scholar is included among the top collaborators of Brian Frederick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Frederick. Brian Frederick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sen, Payel, Yemin Lan, Simone Sidoli, et al.. (2019). Histone Acetyltransferase p300 Induces De Novo Super-Enhancers to Drive Cellular Senescence. Molecular Cell. 73(4). 684–698.e8. 106 indexed citations
2.
Bourne, Gregory T., et al.. (2019). Regulation of Iron Homeostasis By PTG-300 Improves Disease Parameters in Mouse Models for Beta-Thalassemia and Hereditary Hemochromatosis. Blood. 134(Supplement_1). 3540–3540. 11 indexed citations
3.
Bourne, Gregory T., Li Zhao, Ashok Bhandari, et al.. (2017). Hepcidin Mimetic Ptg-300 for Treatment of Ineffective Erythropoiesis and Iron Overload. American Journal of Hematology. 92(8). 3 indexed citations
4.
Mattheakis, Larry, et al.. (2016). P-126 PTG-100, An Oral Peptide Antagonist of Integrin α4β7 that Alters Trafficking of Gut Homing T Cells in Preclinical Animal Models. Inflammatory Bowel Diseases. 22. S48–S48. 8 indexed citations
5.
Bourne, Gregory T., et al.. (2016). P-148 Discovery of Novel Oral Peptide Antagonists of IL-23 Receptor that Are Efficacious in a Rat Model of IBD. Inflammatory Bowel Diseases. 22. S55–S55. 1 indexed citations
6.
Ricketts, M. Daniel, Brian Frederick, Henry Hoff, et al.. (2015). Ubinuclein-1 confers histone H3.3-specific-binding by the HIRA histone chaperone complex. Nature Communications. 6(1). 7711–7711. 98 indexed citations
7.
Chitnis, Nilesh, Dariusz Pytel, Ekaterina Bobrovnikova-Marjon, et al.. (2012). miR-211 Is a Prosurvival MicroRNA that Regulates chop Expression in a PERK-Dependent Manner. Molecular Cell. 48(3). 353–364. 177 indexed citations
8.
Bhandari, Ashok, Brian Frederick, Jennifer M. Green, et al.. (2009). Discovery and Optimization of a TRAIL R2 Agonist for Cancer Therapy. Advances in experimental medicine and biology. 611. 101–103. 15 indexed citations
9.
Holmes, Christopher P., Xianfeng Li, Yijun Pan, et al.. (2008). PTP1B inhibitors: Synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold. Bioorganic & Medicinal Chemistry Letters. 18(8). 2719–2724. 21 indexed citations
10.
Holmes, Christopher P., Xianfeng Li, Yijun Pan, et al.. (2005). Discovery and structure–activity relationships of novel sulfonamides as potent PTP1B inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(19). 4336–4341. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026